WMSA
MYGN icon

Weiss Multi-Strategy Advisers’s Myriad Genetics MYGN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,450
Closed -$221K – 862
2014
Q1 		$221K Sell
6,450
-9,560
-60% -$296K ﹤0.01% 892
2013
Q4 		$336K Buy
16,010
+5,190
+48% +$131K 0.01% 764
2013
Q3 		$254K Buy
+10,820
New +$307K 0.01% 741

Other funds holding MYGN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Weiss Multi-Strategy Advisers's MYGN Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of Myriad Genetics (MYGN) in Q2 2014, closing a stake of 6,450 shares — an estimated $221K sold.

Weiss Multi-Strategy Advisers first reported a position in MYGN in Q3 2013 and held it in 3 quarters. The position peaked at $336K in Q4 2013. 283 funds tracked by Wall St. Rank hold MYGN as of Q2 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Myriad Genetics position as of Q2 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 6,450 Myriad Genetics shares in Q2 2014, an estimated $221K.
  • Weiss Multi-Strategy Advisers first reported a position in Myriad Genetics in Q3 2013 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's Myriad Genetics position peaked at $336K in Q4 2013.
  • 283 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.